Atrys Health, S.A. (FRA:A2T)
Germany flag Germany · Delayed Price · Currency is EUR
2.550
+0.030 (1.19%)
At close: Nov 28, 2025

Atrys Health Statistics

Total Valuation

Atrys Health has a market cap or net worth of EUR 204.86 million. The enterprise value is 441.43 million.

Market Cap204.86M
Enterprise Value 441.43M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Current Share Class 75.87M
Shares Outstanding n/a
Shares Change (YoY) +0.12%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) 3.13%
Owned by Institutions (%) 13.87%
Float 41.75M

Valuation Ratios

PE Ratio n/a
Forward PE 29.80
PS Ratio 0.91
PB Ratio 0.85
P/TBV Ratio n/a
P/FCF Ratio 11.51
P/OCF Ratio 8.80
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.02, with an EV/FCF ratio of 24.80.

EV / Earnings -17.96
EV / Sales 1.95
EV / EBITDA 20.02
EV / EBIT 103.21
EV / FCF 24.80

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.04.

Current Ratio 0.83
Quick Ratio 0.70
Debt / Equity 1.04
Debt / EBITDA 11.36
Debt / FCF 14.07
Interest Coverage 0.19

Financial Efficiency

Return on equity (ROE) is -9.52% and return on invested capital (ROIC) is 0.53%.

Return on Equity (ROE) -9.52%
Return on Assets (ROA) 0.45%
Return on Invested Capital (ROIC) 0.53%
Return on Capital Employed (ROCE) 0.91%
Revenue Per Employee 112,222
Profits Per Employee -12,195
Employee Count2,045
Asset Turnover 0.38
Inventory Turnover 100.32

Taxes

Income Tax -1.06M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -11.76% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -11.76%
50-Day Moving Average 2.88
200-Day Moving Average 2.79
Relative Strength Index (RSI) 38.44
Average Volume (20 Days) 116

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Atrys Health had revenue of EUR 226.24 million and -24.59 million in losses. Loss per share was -0.32.

Revenue226.24M
Gross Profit 56.34M
Operating Income 4.28M
Pretax Income -25.48M
Net Income -24.59M
EBITDA 15.96M
EBIT 4.28M
Loss Per Share -0.32
Full Income Statement

Balance Sheet

The company has 13.99 million in cash and 250.52 million in debt, giving a net cash position of -236.53 million.

Cash & Cash Equivalents 13.99M
Total Debt 250.52M
Net Cash -236.53M
Net Cash Per Share n/a
Equity (Book Value) 241.53M
Book Value Per Share 3.18
Working Capital -19.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.28 million and capital expenditures -5.48 million, giving a free cash flow of 17.80 million.

Operating Cash Flow 23.28M
Capital Expenditures -5.48M
Free Cash Flow 17.80M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 24.90%, with operating and profit margins of 1.89% and -10.87%.

Gross Margin 24.90%
Operating Margin 1.89%
Pretax Margin -11.26%
Profit Margin -10.87%
EBITDA Margin 7.06%
EBIT Margin 1.89%
FCF Margin 7.87%

Dividends & Yields

Atrys Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.12%
Shareholder Yield -0.12%
Earnings Yield -12.00%
FCF Yield 8.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Atrys Health has an Altman Z-Score of 0.58 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.58
Piotroski F-Score 5